Texxon Holding Limited (NPT)
NPT trades on Nasdaq in Consumer Discretionary, Specialty Chemicals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (us-gaap:Revenues), fiscal year ended 2025-06-30, https://www.sec.gov/Archives/edgar/data/2014337/000121390025111812/0001213900-25-111812-index.htm. Net income: SEC 20-F (us-gaap:NetIncomeLoss), fiscal year ended 2025-06-30.
Profile
| Field | Value |
|---|---|
| Ticker | NPT on Nasdaq |
| Sector | Consumer Discretionary |
| Industry | Specialty Chemicals |
| Country | China |
| IPO year | 2025 |
| SEC CIK | 0002014337 |
| SEC industry code | Wholesale-Chemicals & Allied Products |
| Incorporated in | Cayman Islands |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $797.1M |
| Net income | -$933K |
| Operating income | -$601K |
| Net margin | -0.1% |
| Operating margin | -0.1% |
| Revenue growth | +18.5% |
| Cash | $2.5M |
| Total assets | $139.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.0× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "There is substantial doubt about our ability to continue as a going concern." | 20-F 2025-11-18 |
| Cash and burn | $2.5M cash; operating cash flow $581K a quarter. | Report 2025-06-30 |
| Shares outstanding | No cover-page share count in XBRL | None on EDGAR |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | ZH CPA, LLC, Denver, Colorado, United States | PCAOB Form AP 2025-11-25 |
| Late filings, 12 months | 1 NT notice | NT 20-F 2026-11-02 |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2025 2025-06-30 | $797.1M | -$933K | $2.3M | $2.5M | $73.4M | $797.1M | 20-F 2025-11-18 |
| FY 2024 2024-06-30 | $672.7M | $954K | -$30.8M | $273K | $51.6M | $672.7M | 20-F 2025-11-18 |
| FY 2023 2023-06-30 | $552.5M | $2.0M | -$14.2M | $1.3M | No debt tags | $552.5M | 20-F 2025-11-18 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document REGISTRATION STATEMENT | F-1 | 2026-03-25 |
| Latest annual report ANNUAL REPORT | 20-F | 2025-11-18 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-06-30 |
Source: SEC EDGAR submissions feed, 51 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -4.8% |
| 1 month | -21.6% |
| 3 months | -50.4% |
| Year to date | -64.1% |
| 1 year | -49.9% |
| From 52-week high | -91.3% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Specialty Chemicals
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ZONE | Zone Frontier Inc. | $3.15 | -12.50% | $26.8M |
| YHGJ | Yunhong Green CTI Ltd. | $3.28 | +0.31% | $8.6M |
| HWKN | Hawkins Inc. | $148.66 | -0.01% | $3.1B |
| ASH | Ashland Inc. | $75.57 | -1.18% | $3.5B |
| CLX | Clorox Company (The) | $110.17 | +0.65% | $13.3B |
| CSL | Carlisle Companies Incorporated | $389.67 | -1.63% | $15.1B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier